Alberto Martin Cordero
Research Subjects
Alberto Martin Cordero has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Camilo Romero Núñez
DERMAVET Veterinary Hospital, Mexico City, Mexico
5 shared publications - Rafael Heredia Cárdenas
Dermavet Hospital Veterinario José de la Luz Blanco Ciudad de México México
5 shared publications - Galia Sheinberg Waisburd
Dermatología Especializada Centro Veterinario Mexico Ciudad de Mexico Mexico
3 shared publications - Ariadna Flores Ortega
Centro Universitario UAEM-Amecameca, Universidad Autónoma del Estado de México, Amecameca
2 shared publications Galia Sheinberg Waisburd
Dermatología Especializada Centro Veterinario Mexico Ciudad de Mexico Mexico
2 shared publicationsJocelyn Pineda
Centro Universitario UAEM Amecameca, Km. 2.5 Amecameca-Ayapango Highway, 56900, Amecameca de Juarez, estado de Mexico, Mexico
2 shared publications
Latest Publications
- Open Access
- 2 December 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70075
Efficacy of Plant Extract‐Based Solutions Compared to Chlorhexidine and Miconazole Shampoo for the Treatment of Superficial Pyoderma in Dogs
Background: Canine superficial pyoderma (CSP) is common. Antibiotic and potential antiseptic resistance is a rising concern; natural topicals may provide valuable alternative options.Objectives: Compare natural topicals containing essential oils, plant‐extracted essential fatty acids and N‐acetylcysteine to a medicated shampoo with chlorhexidine, miconazole and micronized silver in treating CSP.Animals: Thirty dogs diagnosed with CSP, divided into three groups as outlined below.Materials: Group 1 bathed using a shampoo (PYOclean Shampoo) twice weekly and application of a rinse‐free mousse (PYOclean Mousse) once daily, Group 2 bathed using the same shampoo as above twice weekly and application of a spray (PYOclean Spray) once daily, and Group 3 bathed using a medicated shampoo (Biohex Shampoo) twice weekly.Methods: Cytology, lesion and pruritus visual analogue (PVAS) scores were evaluated on Days (D) 0, 7 and 15.Results: All three groups showed decreased polymorphonuclear cells (PMN) on D15. The reduction was significant, and more significant in Groups 1 and 2 (90.48% and 98.93%) compared to Group 3 (85.96%); extracellular cocci (cocci EC) significantly decreased by 92.8% and 93.38% in Groups 1 and 2, whereas decreased by 81% in Group 3 on D15. The number of yeasts on D15 decreased by 90% in Group 3 and 82% and 92%, respectively, in Groups 1 and 2. Lesion scores decreased on D15 by 90.61% and 87.95% in Groups 1 and 2 and by 62.94% in Group 3. PVAS decreased on D15 by 95.78% and 96.75%, respectively, in Groups 1 and 2 and by 69.88% in Group 3.Conclusion and clinical importance: Efficacy of three natural topicals in treating dogs with superficial pyoderma without adding any systemic antimicrobial drugs was demonstrated. Such solutions can be complementary to medications such as chlorhexidine and miconazole in addressing CSP.
- 2 December 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70075
Open AccessEfficacy of Plant Extract‐Based Solutions Compared to Chlorhexidine and Miconazole Shampoo for the Treatment of Superficial Pyoderma in Dogs
Background: Canine superficial pyoderma (CSP) is common. Antibiotic and potential antiseptic resistance is a rising concern; natural topicals may provide valuable alternative options.Objectives: Compare natural topicals containing essential oils, plant‐extracted essential fatty acids and N‐acetylcysteine to a medicated shampoo with chlorhexidine, miconazole and micronized silver in treating CSP.Animals: Thirty dogs diagnosed with CSP, divided into three groups as outlined below.Materials: Group 1 bathed using a shampoo (PYOclean Shampoo) twice weekly and application of a rinse‐free mousse (PYOclean Mousse) once daily, Group 2 bathed using the same shampoo as above twice weekly and application of a spray (PYOclean Spray) once daily, and Group 3 bathed using a medicated shampoo (Biohex Shampoo) twice weekly.Methods: Cytology, lesion and pruritus visual analogue (PVAS) scores were evaluated on Days (D) 0, 7 and 15.Results: All three groups showed decreased polymorphonuclear cells (PMN) on D15. The reduction was significant, and more significant in Groups 1 and 2 (90.48% and 98.93%) compared to Group 3 (85.96%); extracellular cocci (cocci EC) significantly decreased by 92.8% and 93.38% in Groups 1 and 2, whereas decreased by 81% in Group 3 on D15. The number of yeasts on D15 decreased by 90% in Group 3 and 82% and 92%, respectively, in Groups 1 and 2. Lesion scores decreased on D15 by 90.61% and 87.95% in Groups 1 and 2 and by 62.94% in Group 3. PVAS decreased on D15 by 95.78% and 96.75%, respectively, in Groups 1 and 2 and by 69.88% in Group 3.Conclusion and clinical importance: Efficacy of three natural topicals in treating dogs with superficial pyoderma without adding any systemic antimicrobial drugs was demonstrated. Such solutions can be complementary to medications such as chlorhexidine and miconazole in addressing CSP.
- Open Access
- 3 September 2020
- Published by Veterinary World in Veterinary World
- Vol. 13 (9) , 1760-1763
Topical effect of a specific spot-on treatment made of natural ingredients in rabbits (Oryctolagus cuniculus) with skin problems: A pilot study
Background and Aim: Rabbits often experience skin diseases. The beneficial effects of plant extracts and essential oils are well known in other species, but the properties of these natural ingredients have not been evaluated in rabbits in vivo. The objective of the current study was to evaluate the effect of a topical, commercial solution made of essential oils, plant-extracted polyunsaturated fatty acids, and Vitamin E on rabbits suffering from skin problems. Materials and Methods: Thirty New Zealand rabbits (no sex distinction) were included in this study, with an average weight of 2–3 kg. The rabbits were divided into two groups: The first group was treated with a topical solution made from natural ingredients, and the second was a control group. The rabbits' hair and skin conditions were evaluated on days 1, 14, 28, and 35 after treatment. Data were analyzed using a Kruskal–Wallis range test. Results: Significant differences were determined in terms of glossy hair variability on days 28 and 35 (p≤0.0001). On days 14-35, hair loss was determined to have reduced (p=0.001), and flaking and odor improved in the treatment group, showing increased scores and significant differences (p=0.0001). By contrast, the control group showed stable overall skin and hair score and an increase in the dryness score. Conclusion: The topical application of essential oils and polyunsaturated fatty acids with Vitamin E was able to improve hair shine and skin hydration and reduce flaking, bad odor, and hair loss, improving the general, and cutaneous aspect of rabbits.
- 3 September 2020
- Published by Veterinary World in Veterinary World
- Vol. 13 (9) , 1760-1763
Open AccessTopical effect of a specific spot-on treatment made of natural ingredients in rabbits (Oryctolagus cuniculus) with skin problems: A pilot study
Background and Aim: Rabbits often experience skin diseases. The beneficial effects of plant extracts and essential oils are well known in other species, but the properties of these natural ingredients have not been evaluated in rabbits in vivo. The objective of the current study was to evaluate the effect of a topical, commercial solution made of essential oils, plant-extracted polyunsaturated fatty acids, and Vitamin E on rabbits suffering from skin problems. Materials and Methods: Thirty New Zealand rabbits (no sex distinction) were included in this study, with an average weight of 2–3 kg. The rabbits were divided into two groups: The first group was treated with a topical solution made from natural ingredients, and the second was a control group. The rabbits' hair and skin conditions were evaluated on days 1, 14, 28, and 35 after treatment. Data were analyzed using a Kruskal–Wallis range test. Results: Significant differences were determined in terms of glossy hair variability on days 28 and 35 (p≤0.0001). On days 14-35, hair loss was determined to have reduced (p=0.001), and flaking and odor improved in the treatment group, showing increased scores and significant differences (p=0.0001). By contrast, the control group showed stable overall skin and hair score and an increase in the dryness score. Conclusion: The topical application of essential oils and polyunsaturated fatty acids with Vitamin E was able to improve hair shine and skin hydration and reduce flaking, bad odor, and hair loss, improving the general, and cutaneous aspect of rabbits.
- Open Access
- 27 March 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (3) , e0230753
Evaluation of the effect of afoxalaner with milbemycin 1 oxime in the treatment of rabbits naturally infected with Psoroptes cuniculi
Rabbits (Oryctolagus cuniculi) are very popular as pets. However, problems of otitits caused by Psoroptes cuniculi are one of the main reasons to visit the veterinarian. Isoxazolines are an alternative treatment to treat this mite, and therefore, an evaluation of the effectiveness of oral afoxalaner with milbemycin oxime in rabbits infected with P. cuniculi was carried out. Nineteen rabbits, of New Zealand breed, with otitis due to an infection with P. cuniculi, were treated, whereas six rabbits were left untreated and formed the control group. The ear canals of each individual were examined, through the collection of otic exudate samples with cotton swabs. These were visualized under the microscope to identify the ectoparasite. Each animal was treated with a single oral dose of 2.50 mg / kg of afoxolaner, and 0.50 mg / kg of milbemycin oxime. Clinical signs and lesions associated with the infection, such as the presence of detritus, cerumen and / or scabs, and erythema, were evaluated. After receiving the treatment, all the lesions were classified as: mild, moderate and intense, with a visual analog scale. A week after providing medication, there was a decrease in the lesions of the group treated with Nexgard Spectra®, without further topical or systemic treatment. The decrease was gradual in the treated group and no recurrence was detected of P. cuniculi infection in both ears. Thus, the administration of a single oral dose of afoxolaner with milbemycin oxime was effective for the treatment of P. cuniculi infection in rabbits.
- 27 March 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (3) , e0230753
Open AccessEvaluation of the effect of afoxalaner with milbemycin 1 oxime in the treatment of rabbits naturally infected with Psoroptes cuniculi
Rabbits (Oryctolagus cuniculi) are very popular as pets. However, problems of otitits caused by Psoroptes cuniculi are one of the main reasons to visit the veterinarian. Isoxazolines are an alternative treatment to treat this mite, and therefore, an evaluation of the effectiveness of oral afoxalaner with milbemycin oxime in rabbits infected with P. cuniculi was carried out. Nineteen rabbits, of New Zealand breed, with otitis due to an infection with P. cuniculi, were treated, whereas six rabbits were left untreated and formed the control group. The ear canals of each individual were examined, through the collection of otic exudate samples with cotton swabs. These were visualized under the microscope to identify the ectoparasite. Each animal was treated with a single oral dose of 2.50 mg / kg of afoxolaner, and 0.50 mg / kg of milbemycin oxime. Clinical signs and lesions associated with the infection, such as the presence of detritus, cerumen and / or scabs, and erythema, were evaluated. After receiving the treatment, all the lesions were classified as: mild, moderate and intense, with a visual analog scale. A week after providing medication, there was a decrease in the lesions of the group treated with Nexgard Spectra®, without further topical or systemic treatment. The decrease was gradual in the treated group and no recurrence was detected of P. cuniculi infection in both ears. Thus, the administration of a single oral dose of afoxolaner with milbemycin oxime was effective for the treatment of P. cuniculi infection in rabbits.
- Open Access
- 26 June 2018
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 46, 6
Three Cases of Canine Dermatomyositis-Like Disease
Background: Dermatomyositis is an idiopathic, inflammatory/immunemediated disease of the skin, muscles and bloodvessels of hereditary nature and unclear pathogenesis. This familial disease has been described in certain breeds, especially collies and Shetland sheep dogs and is of rare occurrence in mongrel dogs. To describe and discuss three clinical cases of dermatomyositis-like disease and provide a brief review of the literature.Cases: Three young mongrel dogs are included in this report. Case 1: Mandarino, a 4-year-old mongrel dog, having a history of skin lesions for at least a year. Showed an underweight patient, skin ulcers, crusts, alopecia, peri-ocular scarring causing severe lagophthalmia and a corneal ulcer. Muscle atrophy was most notable in the head and legs; the dog haddifficulty and pain walking. Treatment was initialised with cephalexin 30 mg/kg BID, pentoxifylline 25 mg/kg BID, and prednisone 2.2 mg/kg SID. The patient was presented after two weeks for follow up; the anaemia and skin condition had improved, the weight had increased by 2 kg, dysphagia and locomotor abnormalities were not present. Case 2: Milagros,a mongrel female dog approximately two years of age, rescued from a shelter. Physical examination showed facial alopecia, erythema and scarring of the periocular skin, crusting and scaling in alopecic areas, pinnae tip necrosis and crusting, ear alopecia, tail tip necrosis and crusting. Also present were distal limb alopecia, crusting and ulcers in areas of trauma in the hock and carpal surfaces; some nails presented onychorhexis and onychoschizia. The patient has been treated for12 months with a good clinical outcome, with pentoxifylline, azathioprine 2.2 mg/kg EOD alternating with prednisone 1 mg/kg EOD. Case 3: Chuchito, an 11-month-old male mongrel rescued dog had been previously hospitalised due to his skin condition. Physical examination showed depigmented and alopecic areas in the nasal planum, perioral and periocular areas, and inflammation of the palpebral tissues. Necrosis of the distal pinnae, alopecia and scales were evident, along with sloughing of scales and ulcers. Skin lesions were also present in the distal limbs, and alopecia, erythema and some crusting and scales in the carpal, tarsal and digital areas. Onychodystrophy was present in several digits. This study describes the physical examination and the clinical pathological findings, including skin scrapings, fungal cultures, and skin biopsies, in three dogs with dermatomyositis-like disease, as well as the clinical outcomes after slightly different treatment protocols were used. The biopsy results of two dogs showed ischaemic dermatopathy.Discussion: The most common initial signs of the disease are erythema, desquamation and alopecia in the facial area, ears, distal limbs and pinnae in young puppies aged between two and six months of age, followed by pigmentary changes. Muscular lesions are uncommon; when present, they represent the most severe form of this disease. Dysphagia is a common sign and mega-oesophagus may be present. Patients with muscular disease can manifest difficulty walking, with a stiff high gait. The immune mediated pathogenesis of dermatomyositis can relate to triggering factors in some dogs, such as drugs, infections, paraneoplasms, or toxins. Other potential inducing stressors include oestrus, whelping and excessive solar exposure. Dermatomyositis-like or familiar dermatomyositis is diagnosed using clinical findings, histopathologyof skin and muscle, and muscle physiology studies. Electromyography, breed predisposition and genetic background can be helpful in some cases. The clinical findings and response to the treatment of all three cases were compatible with dermatomyositis-like disease in mongrel dogs.Keywords: dermatomyositis, dermatopathy, vascular disease, inflammatory myopathies, mongrel dog.
- 26 June 2018
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 46, 6
Open AccessThree Cases of Canine Dermatomyositis-Like Disease
Background: Dermatomyositis is an idiopathic, inflammatory/immunemediated disease of the skin, muscles and bloodvessels of hereditary nature and unclear pathogenesis. This familial disease has been described in certain breeds, especially collies and Shetland sheep dogs and is of rare occurrence in mongrel dogs. To describe and discuss three clinical cases of dermatomyositis-like disease and provide a brief review of the literature.Cases: Three young mongrel dogs are included in this report. Case 1: Mandarino, a 4-year-old mongrel dog, having a history of skin lesions for at least a year. Showed an underweight patient, skin ulcers, crusts, alopecia, peri-ocular scarring causing severe lagophthalmia and a corneal ulcer. Muscle atrophy was most notable in the head and legs; the dog haddifficulty and pain walking. Treatment was initialised with cephalexin 30 mg/kg BID, pentoxifylline 25 mg/kg BID, and prednisone 2.2 mg/kg SID. The patient was presented after two weeks for follow up; the anaemia and skin condition had improved, the weight had increased by 2 kg, dysphagia and locomotor abnormalities were not present. Case 2: Milagros,a mongrel female dog approximately two years of age, rescued from a shelter. Physical examination showed facial alopecia, erythema and scarring of the periocular skin, crusting and scaling in alopecic areas, pinnae tip necrosis and crusting, ear alopecia, tail tip necrosis and crusting. Also present were distal limb alopecia, crusting and ulcers in areas of trauma in the hock and carpal surfaces; some nails presented onychorhexis and onychoschizia. The patient has been treated for12 months with a good clinical outcome, with pentoxifylline, azathioprine 2.2 mg/kg EOD alternating with prednisone 1 mg/kg EOD. Case 3: Chuchito, an 11-month-old male mongrel rescued dog had been previously hospitalised due to his skin condition. Physical examination showed depigmented and alopecic areas in the nasal planum, perioral and periocular areas, and inflammation of the palpebral tissues. Necrosis of the distal pinnae, alopecia and scales were evident, along with sloughing of scales and ulcers. Skin lesions were also present in the distal limbs, and alopecia, erythema and some crusting and scales in the carpal, tarsal and digital areas. Onychodystrophy was present in several digits. This study describes the physical examination and the clinical pathological findings, including skin scrapings, fungal cultures, and skin biopsies, in three dogs with dermatomyositis-like disease, as well as the clinical outcomes after slightly different treatment protocols were used. The biopsy results of two dogs showed ischaemic dermatopathy.Discussion: The most common initial signs of the disease are erythema, desquamation and alopecia in the facial area, ears, distal limbs and pinnae in young puppies aged between two and six months of age, followed by pigmentary changes. Muscular lesions are uncommon; when present, they represent the most severe form of this disease. Dysphagia is a common sign and mega-oesophagus may be present. Patients with muscular disease can manifest difficulty walking, with a stiff high gait. The immune mediated pathogenesis of dermatomyositis can relate to triggering factors in some dogs, such as drugs, infections, paraneoplasms, or toxins. Other potential inducing stressors include oestrus, whelping and excessive solar exposure. Dermatomyositis-like or familiar dermatomyositis is diagnosed using clinical findings, histopathologyof skin and muscle, and muscle physiology studies. Electromyography, breed predisposition and genetic background can be helpful in some cases. The clinical findings and response to the treatment of all three cases were compatible with dermatomyositis-like disease in mongrel dogs.Keywords: dermatomyositis, dermatopathy, vascular disease, inflammatory myopathies, mongrel dog.
- 29 December 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (2) , 104-+
Doramectin in the treatment of generalized demodicosis
Background: Generalized demodicosis is a common disease in dogs and doramectin has been reported as a successful treatment. Different treatment protocols using doramectin have not been previously evaluated.Objective: To evaluate whether oral administration of doramectin twice a week is more effective than administration by subcutaneous injection once a week.Animals: Twenty nine privately owned dogs affected with generalized demodicosis.Methods: Dogs randomly received one of two treatments. Sixteen dogs were treated with 600 μg/kg doramectin by subcutaneous injection once a week and 13 dogs received 600 μg/kg doramectin by oral administration twice a week.Results: The mean age of affected dogs was 2.8 and 2.6 years (P= 0.587) and the mean mite number detected at the initial evaluation was 201 and 287 (P= 0.04), respectively, for each group. The mean time to achieve negative skin scrapings was 13 and 12 weeks, respectively (P= 0.955). Adult‐onset demodicosis affected five of 16 and two of 13 dogs, respectively (P= 0.662). The success rate for treatment was 13 of 16 (81%) of dogs receiving subcutaneous injections once a week and 12 of 13 (92%) dogs receiving oral dosaging twice a week. (P= 0.691). Four dogs did not achieve disease remission. In the 12 month follow‐up period, one dog that had received the once a week protocol relapsed after eight weeks of treatment withdrawal. Adverse effects were not observed in any dog.Conclusion: Based on the results of this study, oral administration of doramectin twice a week does not achieve a more rapid resolution of canine generalized demodicosis than administration by subcutaneous injection once a week. The treatment success rate was the same for both protocols.
- 29 December 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (2) , 104-+
Doramectin in the treatment of generalized demodicosis
Background: Generalized demodicosis is a common disease in dogs and doramectin has been reported as a successful treatment. Different treatment protocols using doramectin have not been previously evaluated.Objective: To evaluate whether oral administration of doramectin twice a week is more effective than administration by subcutaneous injection once a week.Animals: Twenty nine privately owned dogs affected with generalized demodicosis.Methods: Dogs randomly received one of two treatments. Sixteen dogs were treated with 600 μg/kg doramectin by subcutaneous injection once a week and 13 dogs received 600 μg/kg doramectin by oral administration twice a week.Results: The mean age of affected dogs was 2.8 and 2.6 years (P= 0.587) and the mean mite number detected at the initial evaluation was 201 and 287 (P= 0.04), respectively, for each group. The mean time to achieve negative skin scrapings was 13 and 12 weeks, respectively (P= 0.955). Adult‐onset demodicosis affected five of 16 and two of 13 dogs, respectively (P= 0.662). The success rate for treatment was 13 of 16 (81%) of dogs receiving subcutaneous injections once a week and 12 of 13 (92%) dogs receiving oral dosaging twice a week. (P= 0.691). Four dogs did not achieve disease remission. In the 12 month follow‐up period, one dog that had received the once a week protocol relapsed after eight weeks of treatment withdrawal. Adverse effects were not observed in any dog.Conclusion: Based on the results of this study, oral administration of doramectin twice a week does not achieve a more rapid resolution of canine generalized demodicosis than administration by subcutaneous injection once a week. The treatment success rate was the same for both protocols.
- 8 October 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (2) , 173
Early onset canine generalized demodicosis
- 8 October 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 29 (2) , 173
Early onset canine generalized demodicosis
- 9 July 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 28 (6) , 622-e152
Fluralaner as a single dose oral treatment for Caparinia tripilis in a pygmy African hedgehog
Background: African pygmy hedgehogs (Atelerix albiventris) are popular pets belonging to the Erinaceidae family of spined mammals. Amongst the most common skin diseases occurring in this species is infestation caused by the mite Caparinia spp. Due to their skin anatomy and spiny coat, detection of skin lesions in these hedgehogs can be difficult. This may result in delays in seeking medical care, which may lead to secondary bacterial infection and self‐inflicted trauma. Multiple therapies have been used in the treatment of this skin condition including ivermectin, amitraz, fipronil and selamectin. A drug which could be administered as a single oral dose would be advantageous to these pets and their owners.Objective: To evaluate the effect of a single oral dose (15 mg/kg) of fluralaner on Caparinia tripilis infestation in the African pygmy hedgehog.Animals: A 10‐month‐old African pygmy hedgehog weighing 184 g.Methods: Response to treatment was monitored by dermatological examination and superficial skin scrapings repeated at 7, 14, 21, 30, 60, 90 and 120 days following fluralaner administration.Results: On Day 7 after treatment, adult mites were observed exhibiting normal movement. On Day 14, only dead mites were observed. No life stages of the mites were found after Day 21.Conclusion and clinical importance: A single oral dose at 15 mg/kg of fluralaner was effective within 21 days after treatment for capariniasis in this case. Further studies are required to evaluate the drug's safety and toxicology in hedgehogs, and to confirm efficacy.
- 9 July 2017
- Published by Wiley in Veterinary Dermatology
- Vol. 28 (6) , 622-e152
Fluralaner as a single dose oral treatment for Caparinia tripilis in a pygmy African hedgehog
Background: African pygmy hedgehogs (Atelerix albiventris) are popular pets belonging to the Erinaceidae family of spined mammals. Amongst the most common skin diseases occurring in this species is infestation caused by the mite Caparinia spp. Due to their skin anatomy and spiny coat, detection of skin lesions in these hedgehogs can be difficult. This may result in delays in seeking medical care, which may lead to secondary bacterial infection and self‐inflicted trauma. Multiple therapies have been used in the treatment of this skin condition including ivermectin, amitraz, fipronil and selamectin. A drug which could be administered as a single oral dose would be advantageous to these pets and their owners.Objective: To evaluate the effect of a single oral dose (15 mg/kg) of fluralaner on Caparinia tripilis infestation in the African pygmy hedgehog.Animals: A 10‐month‐old African pygmy hedgehog weighing 184 g.Methods: Response to treatment was monitored by dermatological examination and superficial skin scrapings repeated at 7, 14, 21, 30, 60, 90 and 120 days following fluralaner administration.Results: On Day 7 after treatment, adult mites were observed exhibiting normal movement. On Day 14, only dead mites were observed. No life stages of the mites were found after Day 21.Conclusion and clinical importance: A single oral dose at 15 mg/kg of fluralaner was effective within 21 days after treatment for capariniasis in this case. Further studies are required to evaluate the drug's safety and toxicology in hedgehogs, and to confirm efficacy.
- 11 August 2016
- Published by Wiley in Veterinary Dermatology
- Vol. 27 (5) , 353-e88
Efficacy of fluralaner in 17 dogs with sarcoptic mange
Background: There are few licensed options for the treatment of canine sarcoptic mange.Objective: To evaluate the efficacy of fluralaner in dogs with sarcoptic mange infestation.Animals: Seventeen dogs with a diagnosis of Sarcoptes scabiei based on positive skin scrapings.Methods: A single dose of oral fluralaner was administered according to the manufacturer's instructions. Assessments of pruritus and lesions were performed every 7 days for 1 month.Results: By Day 14 post‐treatment, skin scrapings from all dogs were negative for mites. At the beginning of the study there was a negative correlation between body weight of the subject and pruritus [Pearson correlation coefficient (PCC) = −0.396, P = 0.007] and a positive correlation between pruritus and lesion severity (PCC 0.755, P = 0.0001). Significant decreases in lesion size and pruritus were observed within the first 14–21 days, respectively, and improvement in these parameters continued until the end of the study at Day 28.Conclusion: Fluralaner was effective in eliminating scabies mites within 14 days and significantly resolved the clinical signs associated with sarcoptic mange within 21 days after a single dose.
- 11 August 2016
- Published by Wiley in Veterinary Dermatology
- Vol. 27 (5) , 353-e88
Efficacy of fluralaner in 17 dogs with sarcoptic mange
Background: There are few licensed options for the treatment of canine sarcoptic mange.Objective: To evaluate the efficacy of fluralaner in dogs with sarcoptic mange infestation.Animals: Seventeen dogs with a diagnosis of Sarcoptes scabiei based on positive skin scrapings.Methods: A single dose of oral fluralaner was administered according to the manufacturer's instructions. Assessments of pruritus and lesions were performed every 7 days for 1 month.Results: By Day 14 post‐treatment, skin scrapings from all dogs were negative for mites. At the beginning of the study there was a negative correlation between body weight of the subject and pruritus [Pearson correlation coefficient (PCC) = −0.396, P = 0.007] and a positive correlation between pruritus and lesion severity (PCC 0.755, P = 0.0001). Significant decreases in lesion size and pruritus were observed within the first 14–21 days, respectively, and improvement in these parameters continued until the end of the study at Day 28.Conclusion: Fluralaner was effective in eliminating scabies mites within 14 days and significantly resolved the clinical signs associated with sarcoptic mange within 21 days after a single dose.